NASDAQ : ROKU
-$0.08 (-0.06%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-17 | Citigroup | Neutral | Neutral | Maintain |
| 2026-06-16 | JP Morgan | Overweight | Neutral | Downgrade |
| 2026-06-16 | Citizens | Market Outperform | Market Perform | Downgrade |
| 2026-06-16 | Evercore ISI Group | Outperform | In Line | Downgrade |
| 2026-06-16 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2026-06-16 | Needham | Buy | Buy | Maintain |
| 2026-06-16 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2026-06-16 | Loop Capital | Buy | Hold | Downgrade |
| 2026-06-16 | Rosenblatt | Buy | Buy | Maintain |
| 2026-06-16 | Wedbush | Outperform | Neutral | Downgrade |
| 2026-06-16 | Susquehanna | Positive | Neutral | Downgrade |
| 2026-06-15 | Baird | Outperform | Neutral | Downgrade |
| 2026-06-15 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-06-15 | Keybanc | Overweight | Sector Weight | Downgrade |
| 2026-06-15 | William Blair | Outperform | Market Perform | Downgrade |
| 2026-06-15 | Needham | Buy | Buy | Maintain |
| 2026-06-12 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-06-09 | Guggenheim | Buy | Buy | Maintain |
| 2026-06-04 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-05-28 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-05-11 | Baird | Outperform | Outperform | Maintain |
| 2026-05-04 | Citigroup | Neutral | Neutral | Maintain |
| 2026-05-01 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-05-01 | Wedbush | Outperform | Outperform | Maintain |
| 2026-05-01 | Guggenheim | Buy | Buy | Maintain |
| 2026-05-01 | Needham | Buy | Buy | Maintain |
| 2026-05-01 | Rosenblatt | Buy | Buy | Maintain |
| 2026-05-01 | Susquehanna | Positive | Positive | Maintain |
| 2026-05-01 | Benchmark | Buy | Buy | Maintain |
| 2026-05-01 | Keybanc | Overweight | Overweight | Maintain |
| 2026-05-01 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-05-01 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-05-01 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-04-24 | Keybanc | Overweight | Overweight | Maintain |
| 2026-04-22 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-17 | Baird | Outperform | Outperform | Maintain |
| 2026-04-13 | Jefferies | Buy | Buy | Maintain |
| 2026-04-06 | Baird | Outperform | Outperform | Maintain |
| 2026-02-16 | Pivotal Research | Buy | Buy | Maintain |
| 2026-02-13 | Needham | Buy | Buy | Maintain |
| 2026-02-13 | Wedbush | Outperform | Outperform | Maintain |
| 2026-02-13 | Rosenblatt | Neutral | Buy | Upgrade |
| 2026-02-13 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-02-13 | Keybanc | Overweight | Overweight | Maintain |
| 2026-02-13 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-02-13 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-02-13 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-02-06 | Oppenheimer | Perform | Outperform | Upgrade |
| 2026-02-03 | Keybanc | Overweight | Overweight | Maintain |
| 2026-01-12 | B of A Securities | Buy | Buy | Maintain |
| 2026-01-08 | Evercore ISI Group | In Line | Outperform | Upgrade |
| 2026-01-05 | Arete Research | Neutral | Buy | Upgrade |